BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Naltrexone (Vivitrol) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Naltrexone (Vivitrol)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07269873-9537@assetmemo.bio
DTSTAMP:20261121T004957Z
DTSTART;VALUE=DATE:20261205
DTEND;VALUE=DATE:20261206
SUMMARY:Naltrexone (Vivitrol): Phase 1 readout est. (NCT07269873)
DESCRIPTION:Naltrexone (Vivitrol)\, phase 1.\nStudy: Safety and PK Study of
  BICX104 With or Without Bupropion Compared to Vivitrol\nEstimated primary
  completion: 5 December 2026. This is a ClinicalTrials.gov estimate\, not 
 a confirmed readout date\, and it can move.\nDrug page: https://assetmemo.
 bio/drug/naltrexone-vivitrol#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07269873
URL:https://assetmemo.bio/drug/naltrexone-vivitrol#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07064564-9537@assetmemo.bio
DTSTAMP:20261121T004957Z
DTSTART;VALUE=DATE:20291001
DTEND;VALUE=DATE:20291002
SUMMARY:Naltrexone (Vivitrol): Phase 1 readout est. (NCT07064564)
DESCRIPTION:Naltrexone (Vivitrol)\, phase 1.\nStudy: iSTEP-N 101b: Pharmaco
 kinetics and Safety Study of iSTEP-N Implant vs Monthly Vivitrol in Health
 y Volunteers\nEstimated primary completion: 1 October 2029. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/naltrexone-vivitrol#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT07064564
URL:https://assetmemo.bio/drug/naltrexone-vivitrol#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
